Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Tumor counterattack--concept and reality.

× No keyword cloud information.

13 in total

Review 1. Mitochondria-centric activation induced cell death of cytolytic T lymphocytes and its implications for cancer immunotherapy.

Authors: Arvind Chhabra
Journal: Vaccine Date: 2010-05-06 Impact factor: 3.641

2. Weapons ovarian epithelial tumors may use in immune escape: an immunohistochemical correlational study.

Authors: Eiman Adel Hasby
Journal: Pathol Oncol Res Date: 2011-12-08 Impact factor: 3.201

3. Implementing a comprehensive approach to the study of health dynamics using the psychoneuroimmunology paradigm.

Authors: Nancy L McCain; Dorothy Patricia Gray; Jeanne M Walter; JoLynne Robins
Journal: ANS Adv Nurs Sci Date: 2005 Oct-Dec Impact factor: 1.824

4. Immune privilege and FasL: two ways to inactivate effector cytotoxic T lymphocytes by FasL-expressing cells.

Authors: Jie-Hui Li; Dalia Rosen; Paul Sondel; Gideon Berke
Journal: Immunology Date: 2002-03 Impact factor: 7.397

5. Distribution of lymphocytes of the alpha(E)beta(7) phenotype and E-cadherin in normal human urothelium and bladder carcinomas.

Authors: J Cresswell; H Robertson; D E Neal; T R Griffiths; J A Kirby
Journal: Clin Exp Immunol Date: 2001-12 Impact factor: 4.330

6. A Fas Ligand (FasL)-Fused Humanized Antibody Against Tumor-Associated Glycoprotein 72 Selectively Exhibits the Cytotoxic Effect Against Oral Cancer Cells with a Low FasL/Fas Ratio.

Authors: Ming-Hsien Chien; Wei-Min Chang; Wei-Jiunn Lee; Yu-Chan Chang; Tsung-Ching Lai; Derek V Chan; Rahul Sharma; Yuan-Feng Lin; Michael Hsiao
Journal: Mol Cancer Ther Date: 2017-03-14 Impact factor: 6.261

Tumor counterattack--concept and reality.

Review 1. Mitochondria-centric activation induced cell death of cytolytic T lymphocytes and its implications for cancer immunotherapy.

2. Weapons ovarian epithelial tumors may use in immune escape: an immunohistochemical correlational study.

3. Implementing a comprehensive approach to the study of health dynamics using the psychoneuroimmunology paradigm.

4. Immune privilege and FasL: two ways to inactivate effector cytotoxic T lymphocytes by FasL-expressing cells.

5. Distribution of lymphocytes of the alpha(E)beta(7) phenotype and E-cadherin in normal human urothelium and bladder carcinomas.

6. A Fas Ligand (FasL)-Fused Humanized Antibody Against Tumor-Associated Glycoprotein 72 Selectively Exhibits the Cytotoxic Effect Against Oral Cancer Cells with a Low FasL/Fas Ratio.

Review 7. Immune surveillance in melanoma: From immune attack to melanoma escape and even counterattack.

Review 8. The many roles of FAS receptor signaling in the immune system.

9. T cell adhesion and cytolysis of pancreatic cancer cells: a role for E-cadherin in immunotherapy?

Review 10. The role of CD95 and CD95 ligand in cancer.